Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple Doses Versus Single Dose of Cefazolin to Prevent Periprosthetic Joint Infection After Revision Arthroplasty: a Multicenter Open-label, Randomized Clinical Trial.

NCT06402591 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT06402591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06402591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple Doses Versus Single Dose of Cefazolin to Prevent Periprosthetic Joint Infection After Revision Arthroplasty: a Multicenter Open-label, Randomized Clinical Trial.
Lead sponsor
Radboud University Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
January 1, 2019
Completion date
December 1, 2024
Enrollment
751 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection pro, infection prosthesis hip and knee, infection, prosthesis related, infection, surgical site, joint infection, surgical site infection